CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 265 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,834,698 | -2.8% | 118,444 | 0.0% | 0.14% | -8.3% |
| Q1 2024 | $1,887,997 | +12.3% | 118,444 | +18.4% | 0.16% | +0.6% |
| Q4 2023 | $1,681,000 | +43.8% | 100,000 | 0.0% | 0.16% | +27.9% |
| Q3 2023 | $1,169,000 | -13.0% | 100,000 | 0.0% | 0.12% | -12.9% |
| Q2 2023 | $1,344,000 | -18.9% | 100,000 | 0.0% | 0.14% | -21.8% |
| Q1 2023 | $1,658,000 | -10.9% | 100,000 | 0.0% | 0.18% | -17.9% |
| Q4 2022 | $1,860,000 | – | 100,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 153,391 | $2,376 | 5.62% |
| GABLES CAPITAL MANAGEMENT INC. | 432,210 | $6,694,934 | 3.50% |
| Altium Capital Management LP | 500,000 | $7,745,000 | 3.16% |
| JW Asset Management, LLC | 413,392 | $6,403,442 | 2.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,127,305 | $141,381,954 | 2.35% |
| Opaleye Management Inc. | 640,000 | $9,913,600 | 2.26% |
| BRIDGER MANAGEMENT, LLC | 184,527 | $2,858,323 | 1.47% |
| Ikarian Capital, LLC | 518,386 | $8,029,799 | 1.40% |
| QSV Equity Investors LLC | 84,137 | $1,303,282 | 1.36% |
| Knott David M Jr | 212,000 | $3,284 | 1.31% |